CK-18 is not normally found in vascular smooth muscle, but is highly expressed during the development of atherosclerotic plaques and has been shown to be elevated in hypertensive patients with NAFLD [174]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.